Suppr超能文献

Brn4和酪氨酸羟化酶协同促进神经干细胞向多巴胺能神经元分化。

Brn4 and TH synergistically promote the differentiation of neural stem cells into dopaminergic neurons.

作者信息

Tan Xuefeng, Zhang Lei, Zhu Huixia, Qin Jianbing, Tian Meiling, Dong Chuanming, Li Haoming, Jin Guohua

机构信息

Department of Anatomy and Neurobiology, The Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, PR China.

Department of Anatomy and Neurobiology, The Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, PR China.

出版信息

Neurosci Lett. 2014 Jun 13;571:23-8. doi: 10.1016/j.neulet.2014.04.019. Epub 2014 Apr 24.

Abstract

Neural stem cells (NSCs) are pluripotent cells capable of differentiation into dopaminergic (DA) neurons, which are the major cell types damaged in Parkinson's disease (PD). Therefore, NSCs are considered the most promising cell source for cell replacement therapy of PD. However, the poor differentiation and maturation of DA neurons and decreased cell survival after transplantation are a challenge. We have previously demonstrated that Brn4, a member of the POU domain family of transcription factors, induced the differentiation of NSCs into neurons and promoted their maturation. In this study, we directly transduced tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis, into NSCs to induce DA neuronal differentiation. However, these DA neurons were morphologically immature and seldom expressed dopamine transporter (DAT), a late marker of mature DA neurons. In contrast, TH co-transfected with Brn4 generated increased number of mature DA neurons. Furthermore, Brn4 significantly induced the expression of glial cell line-derived neurotrophic factor (GDNF) with its receptors GFRα-1 and Ret, which may contribute to the maturation and survival of differentiated DA neurons. Our findings may be of future importance for the use of NSCs in cell replacement therapy of PD.

摘要

神经干细胞(NSCs)是能够分化为多巴胺能(DA)神经元的多能细胞,而多巴胺能神经元是帕金森病(PD)中受损的主要细胞类型。因此,神经干细胞被认为是帕金森病细胞替代治疗最有前景的细胞来源。然而,多巴胺能神经元分化和成熟较差以及移植后细胞存活率降低是一个挑战。我们之前已经证明,POU结构域转录因子家族成员Brn4可诱导神经干细胞分化为神经元并促进其成熟。在本研究中,我们将多巴胺生物合成中的限速酶酪氨酸羟化酶(TH)直接导入神经干细胞以诱导多巴胺能神经元分化。然而,这些多巴胺能神经元在形态上不成熟,很少表达多巴胺转运体(DAT),而多巴胺转运体是成熟多巴胺能神经元的晚期标志物。相比之下,与Brn4共转染的TH产生了更多数量的成熟多巴胺能神经元。此外,Brn4显著诱导胶质细胞源性神经营养因子(GDNF)及其受体GFRα-1和Ret的表达,这可能有助于分化的多巴胺能神经元的成熟和存活。我们的发现对于神经干细胞在帕金森病细胞替代治疗中的应用可能具有未来重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验